Achillion Pharmaceuticals Inc., of New Haven, Conn., appointed Gautam Shah executive vice president.

Alkeus Pharmaceuticals Inc., of Boston, appointed Joshua Boger executive chairman.

Ariel Pharmaceuticals Inc., of Broomfield, Colo., named Lawrence Olanoff board chairman.

Biovest International Inc., of Tampa, Fla., added Eduardo Sotomayor to its scientific advisory board.

Cytos Biotechnology Ltd., of Zurich, Switzerland, named John Berriman and Arthur Krieg vice chairmen of the board.

DARA BioSciences Inc., of Raleigh, N.C., named Christopher Clement president and chief operating officer and David Drutz CEO and chief medical officer.

Ember Therapeutics Inc., of Boston, named Jasbir Seehra chief scientific officer and Jeff Saunders vice president, small-molecule drug discovery.

EnVivo Pharmaceuticals Inc., of Watertown, Mass., added Alfred Sandrock to its board.

Generx Biotechnology Corp., of Worcester, Mass., added Ian Krop and Nuhad Ibrahim to the scientific advisory board of its subsidiary Antigen Express Inc.

GenVec Inc., of Gaithersburg, Md., named Cynthia Collins president and CEO.

InDex Pharmaceuticals AB, of Stockholm, Sweden, added Stig Lokke Pedersen to its board.

Ipierian Inc., of South San Francisco, appointed Pamela Conley vice president of research.

Kancera AB, of Stockholm, Sweden, added Carl-Henrik Heldin to its board.

NanoSmart Pharmaceuticals Inc., of Laguna Hills, Calif., named Paul Glidden vice president of research and development.

Neptune Technologies & Bioressources Inc., of Laval, Quebec, added Harlan Waksal to its board.

Obodies Ltd., of Hamilton, New Zealand, appointed Dick Bellamy chairman of its new science advisory board and added Margaret Brimble, Peter Senter, Mark Baker, Wayne Patrick and Peter Bradley to that board.

Oncobiologics Inc., of Cranbury, N.J., appointed Stephen McAndrew vice president, business development and Vincent Benn vice president, clinical and regulatory affairs. The company also named Joseph Bertino head of its new scientific advisory board.

Organovo Holdings Inc., of San Diego, appointed Eric Michael David chief strategy officer.

Paratek Pharmaceuticals Inc., of Boston, appointed Dennis Molnar CEO and director and Evan Loh chief medical officer and board chairman.

Polynoma LLC, of San Diego, a subsidiary of Hong Kong-based CK Life Sciences International Inc., named John Chiplin CEO.

Promedior Inc., of Malvern, Pa., named Suzanne Bruhn president and CEO.

Provectus Pharmaceuticals Inc., of Knoxville, Tenn., added Doug Ulman to its corporate advisory board.

reMYND NV, of Leven Belgium, added Ajit Shetty to its board.

Talon Therapeutics Inc., of San Mateo, Calif., appointed Thomas DeZao head of commercial operations and planning functions.

TapImmune Inc., of Seattle, added James Fuller to its board.